2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase (nicotinamide adenine dinucleotide phosphate ^+^)
RxNorm 14329
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 14329 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: 2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase (nicotinamide adenine dinucleotide phosphate ^+^).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase (NAD(P)^+^)
(Atom ID: 10794625)
SY
Synonym (SY):
2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase (nicotinamide adenine dinucleotide phosphate ^+^)
(Atom ID: 10794626)
FN
Full form of descriptor (FN):
2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase (nicotinamide adenine dinucleotide phosphate ^+^) (substance)
(Atom ID: 10794627)
SY